Copy For Citation
Gibson C. M., Chi G., Halaby R., Korjian S., Daaboul Y., Jain P., ...More
CIRCULATION, vol.135, no.7, pp.648-655, 2017 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
135
Issue:
7
-
Publication Date:
2017
-
Doi Number:
10.1161/circulationaha.116.025427
-
Journal Name:
CIRCULATION
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.648-655
-
Keywords:
anticoagulants, cardiology, cardiovascular diseases, intracranial hemorrhages, stroke, thrombosis, WARFARIN, OUTCOMES, CARE
-
Hacettepe University Affiliated:
Yes
Abstract
BACKGROUND: Stroke is a morbid and potentially mortal complication among patients hospitalized with acute medical illness. The potential of extended-duration thromboprophylaxis with the factor Xa inhibitor betrixaban to reduce the risk of stroke compared with standard-dose enoxaparin in this population was assessed in this retrospective APEX trial substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).